These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2543801)

  • 1. Ofloxacin: in vitro activity against recently isolated gram-negative bacterial strains.
    Chiaradia V; Pascoli L; Mucignat G; Rubli F; Santini GF
    J Chemother; 1989 Apr; 1(2):80-3. PubMed ID: 2543801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS; Mazens-Sullivan MF; Bartlett RC
    Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of sparfloxacin (AT 4140, RP 64206--SPFX) against 275 multiresistant clinical isolates.
    Giamarellou H; Voutsinas D; Xirouchaki E
    J Chemother; 1992 Feb; 4(1):12-5. PubMed ID: 1328554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
    Hardy DJ
    Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
    Barrett MS; Jones RN; Erwin ME; Johnson DM; Briggs BM
    Diagn Microbiol Infect Dis; 1991; 14(5):389-401. PubMed ID: 1665774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
    Aldridge KE; Henderberg A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.
    Appelbaum PC; Spangler SK; Tamarree T
    Chemotherapy; 1988; 34(1):40-5. PubMed ID: 3127127
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of bacteria of the genus Acinetobacter to antibiotics and ofloxacin].
    Fleischer M; Przondo-Mordarska A; Ruczkowska J
    Med Dosw Mikrobiol; 1991; 43(3-4):103-10. PubMed ID: 1823372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro selections of resistant strains by quinolones.
    López-Bartolomé O; Avial CR; Picazo JJ; Cabronero MC; Campos E
    J Chemother; 1989 Jul; 1(4 Suppl):371-3. PubMed ID: 16312445
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of RX-P873 against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii.
    Flamm RK; Rhomberg PR; Jones RN; Farrell DJ
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2280-5. PubMed ID: 25645834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.
    Soussy CJ; Cluzel M; Ploy MC; Kitzis MD; Morel C; Bryskier A; Courvalin P
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():43-50. PubMed ID: 10404337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of CP-74667 compared with four other fluoroquinolones.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
    Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro activity of ofloxacin and gentamicin against isolates from hospitalised patients.
    Adeyemi-Doro FA; Rotowa NA
    Infection; 1986; 14 Suppl 4():S240-2. PubMed ID: 3469154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
    Hoban D; Grabowski M; Koss J; Weselowski V
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.